venBio Select Advisor »

Intra Cellular Therapies shares owned by venBio Select Advisor

Quarter-by-quarter ownership of Intra Cellular Therapies (ITCI) shares owned by venBio Select Advisor from 13F filings

Historical chart of venBio Select Advisor investment in Intra Cellular Therapies

Tip: Access up to 7 years of quarterly data

All positions including Intra Cellular Therapies held by venBio Select Advisor consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intra Cellular Therapies by venBio Select Advisor

Quarter filed Position value Share count Share price at filing
2025-03-31 $83M 625k 131.92
2024-12-31 $255M 3.1M 83.52
2024-09-30 $223M 3.1M 73.17
2024-06-30 $206M 3.0M 68.49
2024-03-31 $171M 2.5M 69.20
2023-12-31 $162M 2.3M 71.62

More positions owned by venBio Select Advisor

Ascendis Pharma Sponsored ADR (ASND)
United Therapeutics Corp Common (UTHR)
Madrigal Pharmaceuticals Common (MDGL)
Argenx Se Sponsored ADR (ARGX)
Krystal Biotech Common (KRYS)
Arrowhead Pharmaceuticals Common (ARWR)
Kymera Therapeutics Common (KYMR)
Merus N V Common (MRUS)
Avidity Biosciences Common (RNA)
Apellis Pharmaceuticals Common (APLS)
Centessa Pharmaceuticals Sponsored Adr (CNTA)
Uniqure Nv Common (QURE)
Xenon Pharmaceuticals Common (XENE)
Akero Therapeutics Common (AKRO)
Vera Therapeutics Common (VERA)

View all positions for venBio Select Advisor

Top funds holding Intra Cellular Therapies

Huntington National Bank

View all funds holding Intra Cellular Therapies